Beneficial effects of vitamin E on radioiodine induced gastrointestinal damage: an experimental and pathomorphological study.

OBJECTIVES The aim of the present study was to investigate the radioprotective effect of vitamin E in the prevention of radioiodine (RAI) induced gastrointestinal damage. METHOD Twenty-four rats were randomly divided into three groups as follows: Group-1 was untreated control group, Group-2 was orally administered single dose of 111 MBq RAI, and Group-3 was orally administered 111 MBq RAI and 1 mL of oral vitamin E. Vitamin E was started two days before RAI administration and was continued for five days once daily after RAI. Pathomorphological parameters of gastrointestinal tissues (stomach, small intestines and bowels) were measured using Hematoxylin-Eosin and Masson's trichrome staining. RESULTS Varying degrees of inflammation, edema, ulcer, mucosal degeneration, necrosis and fibrosis were seen in the stomach, small intestine and bowel tissues of the rats in both study groups and not in the control group. The differences were statistically significant between these groups for all parameters (p < 0.05). The histopathological damage in the vitamin E treated group was significantly less than the damage in the RAI only group (p < 0.05 for all pathomorphological parameters). CONCLUSION The results of this study showed that vitamin E has a radioprotective property with antiinflammatory and antifibrotic effects protecting against gastrointestinal damage caused by radioiodine (Tab. 3, Fig. 3, Ref. 26).

[1]  M. Korkmaz,et al.  The scintigraphic, biodistribution and histopathological evaluation of the effect of experimental 131I administration on the gastrointestinal system and the demonstration of the Na+/I− symporter by immunohistochemistry in rats , 2018, Nuclear medicine communications.

[2]  G. Koca,et al.  Radioprotective effect of lycopene on the gastrointestinal tract after high-dose radioiodine administration in rat models , 2017, Nuclear medicine communications.

[3]  E. Reboul Vitamin E Bioavailability: Mechanisms of Intestinal Absorption in the Spotlight , 2017, Antioxidants.

[4]  P. Wang,et al.  Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial , 2017, Nuclear medicine communications.

[5]  K. Kısmet,et al.  Melatonin: a hepatoprotective agent against radioiodine toxicity in rats. , 2017, Bratislavske lekarske listy.

[6]  V. Singh,et al.  Radioprotective ef fi cacy of delta-tocotrienol , a vitamin E isoform , is mediated through granulocyte colony-stimulating factor , 2017 .

[7]  P. Geramifar,et al.  Gastrointestinal Side Effects of the Radioiodine Therapy for the Patients with Differentiated Thyroid Carcinoma Two Days after Prescription , 2016, World journal of nuclear medicine.

[8]  Wenbin Li,et al.  Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer , 2016, BioMed research international.

[9]  Q. Jiang Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. , 2014, Free radical biology & medicine.

[10]  A. Fard-Esfahani,et al.  Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma , 2014, Nuclear medicine communications.

[11]  G. Koca,et al.  The effect of short-term vitamin E against radioiodine-induced early lacrimal gland damage , 2013, Annals of Nuclear Medicine.

[12]  A. Fard-Esfahani,et al.  Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? , 2013, Nuclear medicine communications.

[13]  S. Mahdavi,et al.  Radio-protective role of antioxidant agents , 2012, Oncology reviews.

[14]  N. Carrasco,et al.  The Na+/I- symporter mediates active iodide uptake in the intestine. , 2009, American journal of physiology. Cell physiology.

[15]  R. Hawaldar,et al.  Evaluation of the radioprotective effect of turmeric extract and vitamin E in mice exposed to therapeutic dose of radioiodine , 2008, Indian Journal of Clinical Biochemistry.

[16]  K. Marx,et al.  Cell death induced by 131I in a differentiated thyroid carcinoma cell line in vitro: Necrosis or apoptosis? , 2006, Nuclear medicine communications.

[17]  P. Novaes,et al.  Evaluation of radioprotective effect of vitamin E in salivary dysfunction in irradiated rats. , 2006, Archives of oral biology.

[18]  K. Nakajima,et al.  Multifactorial analysis on the short-term side effects occurring within 96 hour after radioiodine-131 therapy for differentiated thyroid carcinoma , 2004, Annals of nuclear medicine.

[19]  A. Collins,et al.  Lipid peroxidation in men after dietary supplementation with a mixture of antioxidant nutrients. , 2004, Bratislavske lekarske listy.

[20]  J. Greenberger,et al.  Mitochondrial Localization of Superoxide Dismutase is Required for Decreasing Radiation-Induced Cellular Damage , 2003, Radiation research.

[21]  M. Krajčovičová-Kudláčková,et al.  Free radical disease prevention and nutrition. , 2003, Bratislavske lekarske listy.

[22]  J. E. Carlson Nuclear Medicine: The Requisites , 1995 .

[23]  J. C. Roberts,et al.  Efficacy of radioprotective agents in preventing small and large bowel radiation injury , 1995, Diseases of the Colon & Rectum.

[24]  Lee G Luna,et al.  Manual of histologic staining methods of the Armed forces institute of pathology , 1968 .

[25]  S. M. Seidlin,et al.  Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. , 1946, Journal of the American Medical Association.

[26]  S. Hertz,et al.  RADIOACTIVE IODINE IN THE STUDY OF THYROID PHYSIOLOGY: VII. The Use of Radioactive Iodine Therapy in Hyperthyroidism , 1946 .